Table 2.
Outcomes of Different Concentrations of Hyaluronidase
| Hyaluronidase Concentration (U/mL) |
Percentage of Orbits Treated | Total Dose in Units, Mean ± SD (range) |
Outcome | ||
|---|---|---|---|---|---|
| Satisfactory Result | Insufficient Treatment | Adverse Effects | |||
| 150 | 66% (103/157) | 495 ± 145 (105–900) | 63% (65/103) | 18% (19/103) | 18% (19/103) |
| 100 | 1% (2/157) | 80 ± 0 | 0% | 100% (2/2) | 0% |
| 75 | 31% (48/157) | 219 ± 95 (37.5–375) | 56% (27/48) | 25% (12/48) | 19% (9/48) |
| 37.5 | 3% (4/157) | 70 ± 39 (19–113) | 0% | 100% (4/4) | 0% |
| Total | 395 ± 193 (19–900) | 59% (92/157) | 24% (37/157) | 18% (28/157) | |